China's pre-COVID-19 normality is expected to come back, as claimed by Zhong Nanshan.
For those who don't know who Nanshan is, he is the former president of the Chinese Medical Association from 2005 to 2009.
Nanshan received the Medal of the Republic, the highest honor in China, making him among the top health experts in the Asian nation.
This is why his predictions are a big deal for Chinese residents. Now, here's what he claims about China's COVID-19 situation.
China's Pre-COVID-19 Normality to Return?
According to South China Morning Post's latest report, Nanshan predicts that China will return to its pre-COVID-19 normality by mid-2023.
"It is highly unlikely that people will be restricted from traveling home for Lunar New Year celebrations in 2023," said the Chinese pulmonologist.
But, he urges visitors and Chinese returning home to improve their health preparations before celebrating the Lunar New Year.
He explained that people should get booster vaccinations first to not develop severe COVID-19 symptoms if they ever get infected.
Nanshan further stated that COVID-19 vaccine booster shots could prevent mass transmission during the Lunar New Year migration, especially in crowded places.
What Other Health Experts Say
Nature Journal reported that many health experts are concerned as China relaxes its zero-COVID policy.
Recently, the Chinese government issued new guidelines to ease some health restrictions.
These include travel restrictions and testing requirements. Aside from this, in China, patients with mild or no COVID-19 symptoms are now allowed to isolate at their houses.
Because of this, medical researchers said that the adjustments made in China's zero-COVID policies could lead to more infections.
Right now, government organizations and independent health companies are making efforts to find solutions on how to prevent the spread of COVID-19.
Recently, U.S. FDA authorized bivalent COVID-19 boosters for children.
Experts also suggested continuing to use COVID-19 rapid tests since they are still efficient against new sub-variants.
For more news updates about COVID-19 and other health topics, keep your tabs open here at TechTimes.